| ¿µ¹® | obesity | ÇÑ±Û | ºñ¸¸Áõ |
|---|---|---|---|
| ¼³¸í | ½Åü¿¡ Áö¹æÀÌ °úÀ×À¸·Î ÃàÀûµÇ¾î °ñ°Ý»ó ¹× À°Ã¼»ó ¿ä±¸ÀÇ ÇѰè ÀÌ»óÀ¸·Î üÁßÀÌ Áõ°¡µÈ »óÅÂÀÌ´Ù. ±×·¯³ª üÁö¹æÀÇ ÃøÁ¤Àº ½±Áö ¾Ê±â ¶§¹®¿¡ ¼öºÐ·ù³ª ±ÙÀ°Áõ°¡ÀÇ °æ¿ì¸¦ »©°í, ÀϹÝÀûÀ¸·Î´Â üÁßÁõ°¡¿Í µ¿ÀǾî·Î »ý°¢µÇ¾î Ç¥ÁØÃ¼Áß(ÀÌ»óüÁß)À» 10~20% ³Ñ´Â °æ¿ì¸¦ ºñ¸¸À̶ó Á¤ÀÇÇÑ´Ù. Èí¼ö Ä®·Î¸®°¡ ¼Òºñ Ä®·Î¸®¸¦ ³ÑÀ» ¶§´Â ±× Â÷¸¦ Áß¼ºÁö¹æÀ¸·Î ÇØ¼ Áö¹æ¼¼Æ÷¿¡ ÃàÀûµÇ¾îÁö´Â °á°ú üÁö¹æÀÌ Áõ°¡ÇÑ´Ù. Äí½ÌÁõÈıº, ½Ã»óÇϺμջó µî¿¡µµ ºñ¸¸ÀÌ ³ªÅ¸³´Ù. ºñ¸¸, ƯÈ÷ º¹ºÎ ºñ¸¸Àº ¿©·¯ Áúȯ, ƯÈ÷ ¼ºÀκ´À̶ó°í ÇÏ´Â ÁúȯÀÇ ¹ß»ý°ú °ü·ÃÀÌ ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ºñ¸¸µµÀÇ Æò°¡¿¡´Â üÁßÀ» ÃøÁ¤ÇÏ´Â ¹æ¹ý, ÇǺÎÁÖ¸§µÎ²² ÃøÁ¤¹ý(͏®ÆÛ¸¦ »ç¿ë)ÀÌ ÀÖ´Ù. ºñ¸¸µµ Áö¼ö¸¦ Æò°¡ÇÏ´Â ÀÓ»óÀûÀÎ ¹æ¹ý¿¡´Â ÀÌ»óüÁß¹ý(modified Broca's method)À¸·Î °¡Àå ½±°Ô »ç¿ëÇÏ´Â ¹æ¹ýÀ̸ç [½ÅÀå(cm)£100]¡¿0.9¸¦ ÀÌ»óüÁßÀ¸·Î °è»êÇÏ¿© ÇöÀçüÁßÀ» ¹éºÐÀ²È½ÃŲ ¹æ¹ýÀÌ´Ù. ºñ¸¸µµ = (½ÇÃøÃ¼ÁߣǥÁØÃ¼Áß)/Ç¥ÁØÃ¼Áß¡¿100%·Î °è»êÇÑ´Ù. ºñ¸¸ÀÇ ¿øÀÎÀ¸·Î´Â À¯ÀüÀû ¿äÀÎ, ȯ°æÀû ¿äÀÎ, ¿¡³ÊÁö ´ë»çÀÇ ÀÌ»ó µîÀÌ ÀÖ´Ù. ºñ¸¸ÀÇ Á¾·ù¿¡´Â ¿øÀο¡ µû¶ó¼, ´Ü¼ø ºñ¸¸°ú ÁõÈļº ºñ¸¸À¸·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ´Ü¼ø ºñ¸¸Àº °ú½Ä°ú ¿îµ¿ ºÎÁ·ÀÌ ±× ¿øÀÎÀ̸ç, ÁõÈļº ºñ¸¸Àº ³»ºÐºñ, ½Ã»óÇϺμº, À¯Àü ¹× ´ë»ç¼º µîÀ¸·Î ¹ß»ýÇÑ´Ù. |
||
| ¿µ¹® | hypogonadism | ÇÑ±Û | »ý½Ä»ù±â´ÉÀúÇÏÁõ |
|---|---|---|---|
| ¼³¸í | Á¤»óÀûÀÎ ³²¼º ¹× ¿©¼ºÀÌ µÇ±â À§Çؼ´Â ½Ã»óÇϺο¡¼ »ý½Ä»ù¹æÃâÈ£¸£¸ó, ³úÇϼöü¿¡¼ Ȳüȣ¸£¸ó°ú ³Æ÷ÀÚ±ØÈ£¸£¸ó, °íȯ¿¡¼´Â ¿À½ºÅз¯¿ò ³¼Ò¿¡¼´Â ¿¡½ºÆ®·Î°Õ°ú Æ÷¸£°Ô½ºÅ×·ÐÀÌ ºÐºñµÇ¾î¾ß ÇÑ´Ù. »ý½Ä»ù±â´ÉÀúÇÏÁõÀº ÀÌ·¯ÇÑ ±âÀü Áß ÀϺΰ¡ °áÇÌµÇ¾î ¼ºÀûÀ¸·Î ¾î¸°ÀÌÀÇ »óŸ¦ ¹þ¾î³ªÁö ¸øÇÑ ¼ºÀûÀ¯Ä¡ ³»Áö ±â´É ÀúÇÏµÈ °æ¿ì¸¦ ¸»ÇÑ´Ù. |
||
| IHH | idiopathic hypogonadotropic hypogonadism; idiopathic hypothalamic hypogonadism; infectious human hep... |
|---|---|
| HHHO | hypotonia, hypomentia, hypogonadism, obesity [syndrome] |
| CHARGE Associations | Coloboma Heart disease Atresia choanae Reta... |
| AADH | alopecia-anosmia-deafness-hypogonadism [syndrome] |
| AHH | alpha-hydrazine analog of histidine; anosmia and hypogonadotropic hypogonadism [syndrome]; arylhydro... |
| DIO | Diet-induced obesity |
|---|---|
| OHS | Obesity Hypoventilation Syndrome |
| %OB | obesity |
| HHG | Hypogonadotrophic hypogonadism |
| HH | Hypogonadotropic Hypogonadism |
| hypothalamic obesity with hypogonadism | A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms. Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism. Origin: L. Fr. G. Dys-, bad, + trophe, nourishment (05 Mar 2000) |
|---|
| male hypogonadism | A state in which testes are present but fail to function normally; may be of gonadal or pituitary origin. Synonym: eunuchism, male hypogonadism. Hypergonadotropic eunuchoidism, eunuchoidism of gonadal origin, commonly accompanied by enhanced levels of pituitary gonadotropins in the blood and urine, as in Klinefelter's syndrome. (05 Mar 2000) |
|---|---|
| primary hypogonadism | Defective gonadal development or function, or both, due to abnormality or loss of the gonad itself. (05 Mar 2000) |
| secondary hypogonadism | Defective gonadal development or function, or both, resulting from inadequate secretion of pituitary gonadotropins. Synonym: hypogonadotropic eunuchoidism, secondary hypogonadism. (05 Mar 2000) |
| hypergonadotropic hypogonadism | Defective gonadal development or function of the gonads, resulting from elevated levels of gonadotropins. (05 Mar 2000) |
| hypogonadism | <endocrinology> A condition resulting from or characterised by abnormally decreased functional activity of the gonads, with retardation of growth and sexual development. (18 Nov 1997) |
| hypogonadism with anosmia | Failure of sexual development secondary to inadequate secretion of pituitary gonadotropins, associated with anosmia due to agenesis of the olfactory lobes of the brain; probably X-linked inheritance. Synonym: Kallmann's syndrome. (05 Mar 2000) |
| hypogonadotropic hypogonadism | Defective gonadal development or function, or both, resulting from inadequate secretion of pituitary gonadotropins. Synonym: hypogonadotropic eunuchoidism, secondary hypogonadism. (05 Mar 2000) |
| familial hypogonadotropic hypogonadism | A group of disorders characterised by failure of sexual development, owing to inadequate secretion of pituitary gonadotropins; perhaps X-linked or autosomal recessive inheritance. (05 Mar 2000) |
| anti-obesity agents | Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity. (12 Dec 1998) |
| central obesity | The deposition of obesity around the trunk sparing the limbs. (27 Sep 1997) |
| risks, obesity-related | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness) (12 Dec 1998) |
| morbid obesity | Obesity sufficient to prevent normal activity or physiologic function, or to cause the onset of a pathologic condition. Simple obesity, obesity resulting when caloric intake exceeds energy expenditure. (05 Mar 2000) |
| diseases, obesity-related | Obesity increases the risk of developing a number of diseases including: Type 2 (adult-onset) diabetes High blood pressure (hypertension) Stroke (cerebrovascular accident or CVA) Heart attack (myocardial infarction or MI) Heart failure (congestive heart failure) Cancer (only certain forms such as prostate and colon cancer) Gallstones and gall bladder disease (cholecystitis) Gout and gouty arthritis Osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back Sleep apnea (failure to breath normally during sleep, lowering blood oxygen) Pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
| obesity | <clinical sign> An increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. Origin: L. Obesus = fat (18 Nov 1997) |
| obesity index | Body weight divided by body volume. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|